SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF THE
SECURITIES EXCHANGE ACT OF 1934
(Exact name of registrant as specified in its charter)
|(State of incorporation or organization)||(I.R.S. Employer Identification No.)|
6800 Broken Sound Parkway NW, Third Floor
Boca Raton, Florida
|(Address of principal executive offices)||(Zip Code)|
Securities to be registered pursuant to Section 12(b) of the Act:
|Title of each class to be so registered||
Name of each exchange on which
each class is to be registered
|Common Stock, par value $0.001 per share||The Nasdaq Stock Market LLC|
If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c) or (e), check the following box. ☒
If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d) or (e), check the following box. ☐
Securities Act registration statement or Regulation A offering statement file number to which this form relates: __________ (if applicable)
Securities to be registered pursuant to Section 12(g) of the Act: None
This Registration Statement on Form 8-A is being filed by TherapeuticsMD, Inc., a Nevada corporation (the “Registrant”), in connection with the registration of its common stock, par value $0.001 per share (the “Common Stock”), under Section 12(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the transfer of the listing of the Common Stock to the Nasdaq Global Select Market of the Nasdaq Stock Market LLC. The Common Stock had previously been registered and listed on the NYSE American LLC under Section 12(b) of the Exchange Act.
Item 1. Description of Registrant’s Securities to be Registered.
For a description of the Common Stock to be registered see the sections entitled “Description of Common Stock” and “Certain Provisions of Nevada Law and Our Charter and Bylaws” in the Registrant’s Registration Statement on Form S-3 filed with the Securities and Exchange Commission on November 5, 2015 and incorporated herein by reference.
Item 2. Exhibits.
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.
|Date: October 6, 2017||By:||/s/ Daniel Cartwright|
|Title:||Chief Financial Officer|